DDMODEL00000001
|
Friberg_2009_Schizophrenia_Prolactin
|
PharmML |
Zinnia Parra-Guillen |
2014/09/24 |
2016/05/24 |
|
DDMODEL00000002
|
Friberg_2009_Schizophrenia_Asenapine_PANSS
|
PharmML |
Zinnia Parra-Guillen |
2014/09/24 |
2016/05/18 |
|
DDMODEL00000003
|
Hamren_2008_diabetes_tesaglitazar
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000004
|
DeWinter_2006_diabetes
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000005
|
Lledo-Garcia_2013_diabetes
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000006
|
Simeoni_2004_oncology_TGI
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/05 |
|
DDMODEL00000007
|
DelBene_2009_oncology_in_vitro
|
PharmML 0.8.x |
Paolo Magni |
2014/09/25 |
2016/10/10 |
|
DDMODEL00000008
|
Rocchetti_2013_oncology_TGI_combo
|
PharmML 0.8.x |
Paolo Magni |
2014/09/26 |
2016/10/10 |
|
DDMODEL00000033
|
Magnetic Marker Monitoring GI Transit Model
|
Original code |
Sven van Dijkman |
2015/11/30 |
2016/10/26 |
|
DDMODEL00000034
|
PK of moxifloxacin in patients with diabetic foot infections
|
Original code |
Sebastian Wicha |
2015/11/30 |
2016/05/18 |
|
DDMODEL00000036
|
Executable_BDQ_M2_PK_DDI_with_LPV-RTV
|
Original code |
Elin Svensson |
2015/11/30 |
2016/06/01 |
|
DDMODEL00000038
|
PKPD_Tcell_mAb_multiplesclerosis
|
Original code |
Anne-Gaelle Dosne |
2015/11/30 |
2016/10/31 |
|
DDMODEL00000039
|
IVGTT Integrated glucose insulin modeI (IGI)
|
Original code |
Moustafa Ibrahim |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000040
|
Furosemide PK with transit compartment absorption
|
Original code |
Rikard Nordgren |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000043
|
Semiphysiological artemisinin PK in healthy subjects
|
Original code |
Gunnar Yngman |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000044
|
Miltefosine PK in European and Indian pediatric and adult leishmaniasis patients
|
Original code |
Thomas Dorlo |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000045
|
Clinical Rifampicin PKPD Model using the Multistate Tuberculosis Pharmacometric Model
|
Original code |
Robin Svensson |
2015/11/30 |
2016/05/25 |
|
DDMODEL00000048
|
Overall Survival model for Sunitinib Treatment in GIST
|
Original code |
Sreenath M Krishnan |
2015/11/30 |
2016/06/03 |
|
DDMODEL00000049
|
TDM1_Antibody_Drug_Conjugate_PK_Model
|
Original code |
Brendan Bender |
2015/11/30 |
2015/12/17 |
|
DDMODEL00000050
|
Rifampicin PKPD model in a tuberculosis mouse using Multistate Tuberculosis Pharmacometric Model
|
Original code |
Chunli Chen |
2015/11/30 |
2015/12/11 |
|
DDMODEL00000055
|
Nielsen2007_semimech_PKPD_antibiotics
|
Original code |
Anders Kristoffersson |
2015/11/30 |
2016/05/25 |
|
DDMODEL00000058
|
Integrated gastric emptying and bile release model
|
Original code |
Benjamin Guiastrennec |
2015/11/30 |
2015/12/16 |
|
DDMODEL00000059
|
PK model of factor VIII in haemophilia A patients
|
Original code |
João Abrantes |
2015/11/30 |
2016/10/27 |
|
DDMODEL00000060
|
Troconiz_2009_epilepsy_NegativeBinomial
|
Original code |
Elodie Plan |
2015/12/01 |
2015/12/14 |
|
DDMODEL00000061
|
Population PK of gentamicin in cancer patients with time-varying covariates
|
Original code |
Kajsa Harling |
2015/12/01 |
2016/05/26 |
|
DDMODEL00000063
|
Weight-HbA1c-Insulin-Glucose model
|
Original code |
Steve Choy |
2015/12/01 |
2015/12/11 |
|
DDMODEL00000065
|
TTE Paediatric Ciclosporin Model
|
Original code |
Gopichand Gottipati |
2015/12/01 |
2015/12/15 |
|
DDMODEL00000066
|
Ueckert 2016 ADAS-cog IRT model
|
Original code |
Sebastian Ueckert |
2015/12/01 |
2016/10/17 |
|
DDMODEL00000067
|
The Betacell dynamics, Insulin and Glucose (BIG) Model
|
Original code |
Eric Strömberg |
2015/12/01 |
2015/12/10 |
|
DDMODEL00000069
|
Savic_transit_abs_glibenclamide_pk_original
|
Original code |
Gustaf Wellhagen |
2015/12/03 |
2016/10/14 |
|
DDMODEL00000070
|
Population PK of edoxaban and main metabolite in renal impairment
|
Original code |
Siv Jonsson |
2015/12/03 |
2016/10/06 |
|
DDMODEL00000073
|
OGTT Integrated Glucose-Insulin (IGI) Model
|
Original code |
Siti Sheikh Ghadzi |
2015/12/03 |
2016/10/19 |
|
DDMODEL00000076
|
Yan_2011_EPO_biosimilar_PKPD
|
Original code |
Celine Sarr |
2015/12/09 |
2016/05/20 |
|
DDMODEL00000077
|
Krzyzanski_2010_Filgastrim_PKPD
|
Original code |
Celine Sarr |
2015/12/09 |
2016/05/23 |
|
DDMODEL00000078
|
Chalret_2014_Abexinostat
|
PharmML |
Vincent Croixmarie |
2015/12/09 |
2016/02/12 |
|
DDMODEL00000085
|
Midazolam_PK_Morbidly_obese_Healthy_volunteers
|
Original code |
Margreke Brill |
2015/12/10 |
2016/06/01 |
|
DDMODEL00000087
|
Benson 2014 - FAAH Inhibitors Systems Pharmacology Model for Pain
|
PharmML |
Phylinda Chan |
2015/12/10 |
2016/05/25 |
|
DDMODEL00000089
|
Chan 2010 - HIV PKPD Viral Load Model
|
PharmML |
Phylinda Chan |
2015/12/10 |
2016/05/25 |
|
DDMODEL00000090
|
Claret_2009_oncology_capecitabine_TGI
|
PharmML |
Nadia Terranova |
2015/12/10 |
2016/07/13 |
|
DDMODEL00000091
|
Van Cauter C-peptide model
|
PharmML |
Roberto Bizzotto |
2015/12/10 |
2016/05/18 |
|
DDMODEL00000092
|
Parkinson_2013_CardiacSafety_Dog_Translational
|
Original code |
Amy Cheung |
2015/12/10 |
2015/12/11 |
|
DDMODEL00000093
|
WählbyHamrénJohansson_2015_CardiacSafety_TQT
|
Original code |
Amy Cheung |
2015/12/10 |
2015/12/11 |
|
DDMODEL00000094
|
Insulin sensitivity from labeled IVGTT
|
PharmML |
Roberto Bizzotto |
2015/12/10 |
2016/05/18 |
|
DDMODEL00000096
|
Terranova_2013_oncology_TGI_combo
|
PharmML 0.8.x |
Paolo Magni |
2015/12/10 |
2016/10/10 |
|
DDMODEL00000098
|
Holford 2008 diabetes progression
|
Original code |
Nick Holford |
2015/12/11 |
2015/12/14 |
|
DDMODEL00000101
|
Overgaard’s beta cell model for insulin secretion
|
PharmML |
Roberto Bizzotto |
2015/12/11 |
2016/09/20 |
|
DDMODEL00000102
|
Meibohm_2013_oncology_EMD525797_TMDD
|
PharmML |
Nadia Terranova |
2015/12/11 |
2016/07/18 |
|
DDMODEL00000103
|
Trefz_2015_metabolism_Kuvan_TurnoverKPD
|
PharmML |
Nadia Terranova |
2015/12/11 |
2016/07/18 |
|
DDMODEL00000104
|
Time to conversion of acute A-fib after intravenous digoxin
|
Original code |
Shijun Wang |
2015/12/11 |
2016/06/03 |
|
DDMODEL00000106
|
Krippendorff model for receptor-mediated endocytosis
|
PharmML |
Zinnia Parra-Guillen |
2015/12/11 |
2016/07/15 |
|